CD4 and esophageal squamous cell carcinoma: In this study, we found that ESCC patients having low risk score had remarkably higher levels in most immune cells, including Plasma cells, regulatory T cells, Monocytes, Basophils, Memory B cells, Myocytes, pro B cells, and CD4+ T cells.